| 000 | 01083 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517151700.0 | ||
| 264 | 0 | _c20180418 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a2212-3873 | ||
| 024 | 7 |
_a10.2174/1871530317666170424102332 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilano, Walter | |
| 245 | 0 | 0 |
_aHyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach. _h[electronic resource] |
| 260 |
_bEndocrine, metabolic & immune disorders drug targets _c2017 |
||
| 300 |
_a38-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperprolactinemia _xblood |
| 650 | 0 | 4 |
_aProlactin _xblood |
| 650 | 0 | 4 |
_aSchizophrenia _xblood |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aColletti, Chiara | |
| 700 | 1 | _aCapasso, Anna | |
| 773 | 0 |
_tEndocrine, metabolic & immune disorders drug targets _gvol. 17 _gno. 1 _gp. 38-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871530317666170424102332 _zAvailable from publisher's website |
| 999 |
_c27110802 _d27110802 |
||